Skip to main content

Advertisement

SpringerLink
Log in

Melatonin: possible implications for the postoperative and critically ill patient

  • Review
  • Published:
Intensive Care Medicine Aims and scope Submit manuscript

Abstract

There is increasing interest in the hormone melatonin in postoperative and critically ill patients. The roles of melatonin in the regulation of the sleep-wake cycle, resetting of circadian rhythm disturbances and its extensive antioxidant activity have potential applications in these patient groups. The interaction between melatonin and the stresses of surgery and critical illness are explored in the context of circadian rhythms, sleep disorders and delirium. The antioxidant activity is discussed in terms of the reduction of ischaemic reperfusion injury, prevention of multi-organ failure and treatment of sepsis. Unfortunately, there is currently insufficient evidence that exogenous melatonin is effective in preventing or treating postoperative delirium. Similarly, in the critically ill patient, sleep disorders are associated with disrupted melatonin circadian secretion, but there is a paucity of data to support routine exogenous melatonin supplementation. More clinical evidence to confirm the potential benefits of melatonin therapy is required before it can be routinely used in the postoperative or critically ill patient.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Claustrat B, Brun J, David M, Sassolas G, Chazot G (1992) Melatonin and jet lag: confirmatory result using a simplified protocol. Biol Psychiatry 32:705–711

    Article  PubMed  CAS  Google Scholar 

  2. Lissoni P, Barni S, Ardizzoia A, Paolorossi F, Crispino S, Tancini G, Tisi E, Archili C, De Toma D, Pipino G (1992) Randomized study with the pineal hormone melatonin versus supportive care alone in advanced nonsmall cell lung cancer resistant to a first-line chemotherapy containing cisplatin. Oncology 49:336–339

    Article  PubMed  CAS  Google Scholar 

  3. Dahlitz M, Alvarez B, Vignau J, English J, Arendt J, Parkes JD (1991) Delayed sleep phase syndrome response to melatonin. Lancet 337:1121–4

    Article  PubMed  CAS  Google Scholar 

  4. Sack RL, Brandes RW, Kendall AR, Lewy AJ (2000) Entrainment of free-running circadian rhythms by melatonin in blind people. N Engl J Med 343:1070–7

    Article  PubMed  CAS  Google Scholar 

  5. Garfinkel D, Laudon M, Nof D, Zisapel N (1995) Improvement of sleep quality in elderly people by controlled-release melatonin. Lancet 346:541–544

    Article  PubMed  CAS  Google Scholar 

  6. Reiter RJ, Tan DX, Sainz RM, Mayo JC, Lopez-Burillo S (2002) Melatonin: Reducing the toxicity and increasing the efficacy of drugs. J Pharm Pharmacol 54:1299–1321

    Article  PubMed  CAS  Google Scholar 

  7. Naguib M, Samarkandi AH (1999) Premedication with melatonin: a double-blind, placebo-controlled comparison with midazolam. Br J Anaesth 82:875–80

    PubMed  CAS  Google Scholar 

  8. Naguib M, Hammond DL, Schmid PG 3rd, Baker MT, Cutkomp J, Queral L, Smith T (2003) Pharmacological effects of intravenous melatonin: comparative studies with thiopental and propofol. Br J Anaesth 90:504–507

    Article  PubMed  CAS  Google Scholar 

  9. Ryan DW (2002) Tried any melatonin lately? Care of the Critically Ill 18:132

    Google Scholar 

  10. Lane EA, Moss HB (1985) Pharmacokinetics of melatonin in man: first pass hepatic metabolism. J Clin Endocrinol METAB 61:1214–1216

    Article  PubMed  CAS  Google Scholar 

  11. Sharma M, Palacios Bois J, Schwartz G, Iskandar H, Thakur M, Quirion R, Nair NP (1989) Circadian rhythms of melatonin and cortisol in aging. Biol Psychiatry 25:305–319

    Article  PubMed  CAS  Google Scholar 

  12. Bubenik GA (2002) Gastrointestinal melatonin: localization, function, and clinical relevance. Dig Dis Sci 47:2336–2348

    Article  PubMed  CAS  Google Scholar 

  13. Sack RL, Hughes RJ, Edgar DM, Lewy AJ (1997) Sleep-promoting effects of melatonin: at what dose, in whom, under what conditions, and by what mechanisms? Sleep 20:908–915

    PubMed  CAS  Google Scholar 

  14. Pang SF, Dubocovich ML, Brown GM (1993) Melatonin receptors in peripheral tissues: a new area of melatonin research. Biol Signals 2:177–180

    Article  PubMed  CAS  Google Scholar 

  15. Di WL, Djahanbakhch O, Kadva A, Street C, Silman R (1999) The pineal and extra-pineal origins of 5-sulphatoxy N-acetyl-serotonin in humans. J Pineal Res 26:221–226

    Article  Google Scholar 

  16. Di WL, Kadva A, Johnston A, Silman R (1997) Variable bioavailability of oral melatonin. N Engl J Med 336:1028–1029

    Article  Google Scholar 

  17. DeMuro RL, Nafziger AN, Blask DE, Menhinick AM, Bertino JS Jr (2000) The absolute bioavailability of oral melatonin. J Clin Pharmacol 40:781–784

    Article  PubMed  CAS  Google Scholar 

  18. Hartter S, Ursing C, Morita S, Tybring G, von Bahr C, Christensen M, Rojdmark S, Bertilsson L (2001) Orally given melatonin may serve as a probe drug for cytochrome P450 1A2 activity in vivo: a pilot study. Clin Pharmacol Ther 70:10–16

    Article  PubMed  CAS  Google Scholar 

  19. Bojkowski CJ, Arendt J, Shih MC, Markey SP (1987) Melatonin secretion in humans assessed by measuring its metabolite 6-sulphatoxymelatonin. Clin Chem 33:1343–1348

    PubMed  CAS  Google Scholar 

  20. Mallo C, Zadan R, Galy G, Vermeulen E, Brun J, Chazot G, Claustrat B (1990) Pharmacokinetics of melatonin in man after intravenous infusion and bolus injection. Eur J Clin Pharmacol 38:297–301

    Article  PubMed  CAS  Google Scholar 

  21. Iguchi H, Kato KI, Ibayashi H (1982) Melatonin serum levels and metabolic clearance rate in patients with liver cirrhosis. J Clin Endocrinol METAB 54:1025–1027

    Article  PubMed  CAS  Google Scholar 

  22. Vakkuri O, Leppaluoto J, Kauppila A (1985) Oral administration and distribution of melatonin in human serum, saliva and urine. Life Sci 37:489–495

    Article  PubMed  CAS  Google Scholar 

  23. Aldhous M, Franey C, Wright J, Arendt J (1985) Plasma concentrations of melatonin in man following oral absorption of different preparations. Br J Clin Pharmacol 19:517–521

    PubMed  CAS  Google Scholar 

  24. Reiter RJ, Tan DX (2003) What constitutes a physiological concentration of melatonin? J Pineal Res 34:79–80

    Article  PubMed  CAS  Google Scholar 

  25. Selmaoui B, Touitou Y (2003) Reproducibility of the circadian rhythms of serum cortisol and melatonin in healthy subjects: a study of three different 24-h cycles over six weeks. Life Sci 73:3339–3349

    Article  PubMed  CAS  Google Scholar 

  26. Reber A, Huber PR, Ummenhofer W, Gurtler CM, Zurschmiede C, Drewe J, Schneider M (1998) General anaesthesia for surgery can influence circulating melatonin during daylight hours. Acta Anaesthesiol Scand 42:1050–1056

    Article  PubMed  CAS  Google Scholar 

  27. Uchida K, Aoki T, Takahashi K, Iigo M, Hattori A, Suzuki T (1995) Perioperative plasma melatonin levels in patients with cardiac and esophageal surgery. St Marianna Med J 23:353–360

    Google Scholar 

  28. Guo X, Kuzumi E, Charman SC, Vuylsteke A (2002) Perioperative melatonin secretion in patients undergoing coronary artery bypass grafting. Anesth Analg 94:1085–1091

    Article  PubMed  CAS  Google Scholar 

  29. Uchida K, Aoki T, Ishizuka B (1999) Postoperative delirium and plasma melatonin. Med Hypotheses 53:103–106

    Article  PubMed  CAS  Google Scholar 

  30. Govitrapong P, Pariyanonth M, Ebadi M (1992) The presence and actions of opioid receptors in bovine pineal gland. J Pineal Res 13:124–132

    Article  PubMed  CAS  Google Scholar 

  31. Brismar K, Hylander B, Eliasson K, Rossner S, Wetterberg L (1988) Melatonin secretion related to side effects of beta-blockers from the central nervous system. Acta Med Scand 223:525–530

    Article  PubMed  CAS  Google Scholar 

  32. Stoschitzky K, Sakotnik A, Lercher P, Zweiker R, Maier R, Liebmann P, Lindner W (1999) Influence of beta-blockers on melatonin release. Eur J Clin Pharmacol 55:111–115

    Article  PubMed  CAS  Google Scholar 

  33. McIntyre IM, Burrows GD, Norman TR (1988) Suppression of plasma melatonin by a single dose of the benzodiazepine alprazolam in humans. Biol Psychiatry. 24:108–112

    Article  PubMed  CAS  Google Scholar 

  34. Monteleone P, Forziati D, Orazzo C, Maj M (1989) Preliminary observations on the suppression of nocturnal plasma melatonin levels by short-term administration of diazepam in humans. J Pineal Res 6:253–258

    Article  PubMed  CAS  Google Scholar 

  35. Yuwiler A (1989) Effects of steroids on serotonin-N-acetyltransferase activity of pineals in organ culture. J Neurochem 52:46–53

    Article  PubMed  CAS  Google Scholar 

  36. Iuvone PM, Besharse JC (1986) Involvement of calcium in the regulation of serotonin N- acetyltransferase in retina. J Neurochem 46:82–88

    Article  PubMed  CAS  Google Scholar 

  37. Meyer AC, Nieuwenhuis JJ, Kociszewska VJ, Joubert WS, Meyer BJ (1986) Dihydropyridine calcium antagonists depress the amplitude of the plasma melatonin cycle in baboons. Life Sci 39:1563–1569

    Article  PubMed  CAS  Google Scholar 

  38. Murphy PJ, Myers BL, Badia P (1996) Nonsteroidal anti-inflammatory drugs alter body temperature and suppress melatonin in humans. Physiol Behav 59:133–139

    Article  PubMed  CAS  Google Scholar 

  39. Munoz-Hoyos A, Fernandez-Garcia JM, Molina-Carballo A, Macias M, Escames G, Ruiz-Cosano C, Acuna-Castroviejo D (2000) Effect of clonidine on plasma ACTH, cortisol and melatonin in children. J Pineal Res 29:48–53

    Article  PubMed  CAS  Google Scholar 

  40. Monteleone P, Tortorella A, Borriello R, Natale M, Cassandro P, Maj M (1997) Suppression of nocturnal plasma melatonin levels by evening administration of sodium valproate in healthy humans. Biol Psychiatry 41:336–341

    Article  PubMed  CAS  Google Scholar 

  41. Karkela J, Vakkuri O, Kaukinen S, Huang WQ, Pasanen M (2002) The influence of anaesthesia and surgery on the circadian rhythm of melatonin. Acta Anaesthesiol Scand 46:30–36

    Article  PubMed  CAS  Google Scholar 

  42. Messner M, Huether G, Lorf T, Ramadori G, Schworer H (2001) Presence of melatonin in the human hepatobiliary-gastrointestinal tract. Life Sci 69:543–551

    Article  PubMed  CAS  Google Scholar 

  43. Cronin AJ, Keifer JC, Davies MF, King TS, Bixler EO (2000) Melatonin secretion after surgery. Lancet 356:1244–1245

    Article  PubMed  CAS  Google Scholar 

  44. Nishimura S, Fujino Y, Shimaoka M, Hagihira S, Taenaka N, Yoshiya I (1998) Circadian secretion patterns of melatonin after major surgery. J Pineal Res 25:73–77

    Article  PubMed  CAS  Google Scholar 

  45. Miyazaki T, Kuwano H, Kato H, Ando H, Kimura H, Inose T, Ohno T, Suzuki M, Nakajima M, Manda R, Fukuchi M, Tsukada K (2003) Correlation between serum melatonin circadian rhythm and intensive care unit psychosis after thoracic esophagectomy. Surgery 133:662–668

    Article  PubMed  Google Scholar 

  46. Derenzo J, Macknight B, DiVittore NA, Bonafide CP, Cronin AJ (2005) Postoperative elevated cortisol excretion is not associated with suppression of 6-sulfatoxymelatonin excretion. Acta Anaesthesiol Scand 49:52–57

    Article  PubMed  CAS  Google Scholar 

  47. Kellner M, Yassouridis A, Manz B, Steiger A, Holsboer F, Wiedemann K (1997) Corticotropin-releasing hormone inhibits melatonin secretion in healthy volunteers—a potential link to low-melatonin syndrome in depression? Neuroendocrinology 65:284–290

    Article  PubMed  CAS  Google Scholar 

  48. Rosenberg-Adamsen S, Kehlet H, Dodds C, Rosenberg J (1996) Postoperative sleep disturbances: mechanisms and clinical implications. Br J Anaesth 76:552–559

    PubMed  CAS  Google Scholar 

  49. Mundigler G, Delle-Karth G, Koreny M, Zehetgruber M, Steindl-Munda P, Marktl W, Ferti L, Siostrzonek P (2002) Impaired circadian rhythm of melatonin secretion in sedated critically ill patients with severe sepsis. Crit Care Med 30:536–540

    Article  PubMed  CAS  Google Scholar 

  50. Parfitt AG, Klein DC (1976) Sympathetic nerve endings in the pineal gland protect against acute stress-induced increase in N-acetyltransferase (EC 2.3.1.5.) activity. Endocrinology 99:840–851

    Article  PubMed  CAS  Google Scholar 

  51. Berlin I, Touitou Y, Guillemant S, Danjou P, Puech AJ (1995) Beta-adrenoceptor agonists do not stimulate daytime melatonin secretion in healthy subjects. A double blind placebo controlled study. Life Sci 56:325–331

    Article  Google Scholar 

  52. Frisk U, Olsson J, Nylen P, Hahn RG (2004) Low melatonin excretion during mechanical ventilation in the intensive care unit. Clin Sci 107:47–53

    Article  PubMed  CAS  Google Scholar 

  53. Sam S, Corbridge TC, Mokhlesi B, Comellas AP, Molitch ME (2004) Cortisol levels and mortality in severe sepsis. Clin Endocrinol (Oxf) 60:29–35

    Article  CAS  Google Scholar 

  54. Olofsson K, Alling C, Lundberg D, Malmros C (2004) Abolished circadian rhythm of melatonin secretion in sedated and artificially ventilated intensive care patients. Acta Anaesthesiol Scand 48:679–684

    Article  PubMed  CAS  Google Scholar 

  55. Gabor JY, Cooper AB, Hanly PJ (2001) Sleep disruption in the intensive care unit. Curr Opin Crit Care 7:21–27

    Article  PubMed  CAS  Google Scholar 

  56. Cooper AB, Thornley KS, Young GB, Slutsky AS, Stewart TE, Hanly PJ (2000) Sleep in critically ill patients requiring mechanical ventilation. Chest 117:809–818

    Article  PubMed  CAS  Google Scholar 

  57. Shilo L, Dagan Y, Smorjik Y, Weinberg U, Dolev S, Komptel B, Balaum H, Shenkman L (1999) Patients in the intensive care unit suffer from severe lack of sleep associated with loss of normal melatonin secretion pattern. Am J Med Sci 317:278–281

    Article  PubMed  CAS  Google Scholar 

  58. Shilo L, Dagan Y, Smorjik Y, Weinberg U, Dolev S, Komptel B, Shenkman L (2000) Effect of melatonin on sleep quality of COPD intensive care patients: a pilot study. Chronobiol Int 17:71–76

    Article  PubMed  CAS  Google Scholar 

  59. MacFarlane JG, Cleghorn JM, Brown GM, Streiner DL (1991) The effects of exogenous melatonin on the total sleep time and daytime alertness of chronic insomniacs: A preliminary study. Biol Psychiatry 30:371–376

    Article  PubMed  CAS  Google Scholar 

  60. Helfrich E, Neef C, Hylkema BS, Wilts G, Merkus FWHM (2004) Obtaining a normal sleep-wake pattern: Intranasal administration of melatonin in intensive care patients. Pharm Weekbl 139:82–85

    Google Scholar 

  61. Bourne RS, Mills GH (2004) Sleep disruption in critically ill patients—pharmacological considerations. Anaesthesia 59:374–384

    Article  PubMed  CAS  Google Scholar 

  62. Zhdanova IV, Wurtman RJ, Morabito C, Piotrovska VR, Lynch HJ (1996) Effects of low oral doses of melatonin, given 2–4 h before habitual bedtime, on sleep in normal young humans. Sleep 19:423–431

    PubMed  CAS  Google Scholar 

  63. Paul MA, Gray G, Kenny G, Pigeau RA (2003) Impact of melatonin, zaleplon, zopiclone, and temazepam on psychomotor performance. Aviat Space Environ Med 74:1263–1270

    PubMed  CAS  Google Scholar 

  64. Cajochen C, Kräuchi K, Wirz Justice A (2003) Role of melatonin in the regulation of human circadian rhythms and sleep. J Neuroendocrinol 15:432–437

    Article  PubMed  CAS  Google Scholar 

  65. Ely EW, Shintani A, Truman B, Speroff T, Gordon SM, Harrell FE Jr, Inouye SK, Bernard GR, Dittus RS (2004) Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit. JAMA 291:1753–1762

    Article  PubMed  CAS  Google Scholar 

  66. Jacobi J, Fraser GL, Coursin DB, Riker RR, Fontaine D, Wittbrodt ET, Chalfin DB, Masica MF, Bjerke HS, Coplin WM, Crippen DW, Fuchs BD, Kelleher RM, Marik PE, Nasraway SA Jr, Murray-Michael J, Peruzzi WT, Lumb PD (2002) Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. Crit Care Med 30:119–141

    Article  PubMed  Google Scholar 

  67. Miles A, Philbrick DRS (1988) Melatonin and psychiatry. Biol Psychiatry 23:405–425

    Article  PubMed  CAS  Google Scholar 

  68. Shigeta H, Yasui A, Nimura Y, Machida N, Kageyama M, Miura M, Menjo M, Ikeda K (2001) Postoperative delirium and melatonin levels in elderly patients. Am J Surg 182:449–454

    Article  PubMed  CAS  Google Scholar 

  69. Balan S, Leibovitz A, Zila SO, Ruth M, Chana W, Yassica B, Rahel B, Richard G, Neumann E, Blagman B, Habot B (2003) The relation between the clinical subtypes of delirium and the urinary level of 6-SMT. J Neuropsychiatry Clin Neurosci 15:363–366

    PubMed  Google Scholar 

  70. Lewis MC, Barnett SR (2004) Postoperative delirium: The tryptophan dyregulation model. Med Hypotheses 63:402–406

    Article  PubMed  CAS  Google Scholar 

  71. Hanania M, Kitain E (2002) Melatonin for treatment and prevention of postoperative delirium. Anesth Analg 94:338–339

    Article  PubMed  Google Scholar 

  72. McGuire BE, Basten CJ, Ryan CJ, Gallagher J (2000) Intensive care unit syndrome: a dangerous misnomer. Arch Intern Med 160:906–909

    Article  PubMed  CAS  Google Scholar 

  73. Lundstrom M, Edlund A, Karlsson S, Brannstrom B, Bucht G, Gustafson Y (2005) A multifactorial intervention program reduces the duration of delirium, length of hospitalization, and mortality in delirious patients. J Am Geriatr Soc 53:622–628

    Article  PubMed  Google Scholar 

  74. Macdonald J, Galley HF, Webster NR (2003) Oxidative stress and gene expression in sepsis. Br J Anaesth 90:221–232

    Article  PubMed  CAS  Google Scholar 

  75. Cowley HC, Bacon PJ, Goode HF, Webster NR, Jones JG, Menon DK (1996) Plasma antioxidant potential in severe sepsis: a comparison of survivors and nonsurvivors. Crit Care Med 24:1179–1183

    Article  PubMed  CAS  Google Scholar 

  76. Pascual C, Karzai W, Meier-Hellmann A, Oberhoffer M, Horn A, Bredle D, Reinhart K (1998) Total plasma antioxidant capacity is not always decreased in sepsis. Crit Care Med 26:705–709

    Article  PubMed  CAS  Google Scholar 

  77. Sewerynek E, Melchiorri D, Reiter RJ, Ortiz GG, Lewinski A (1995) Lipopolysaccharide-induced hepatotoxicity is inhibited by the antioxidant melatonin. Eur J Pharmacol 293:327–334

    Article  PubMed  CAS  Google Scholar 

  78. Yerer MB, Aydogan S, Yapislar H, Yalcin O, Kuru O, Baskurt OK (2003) Melatonin increases glutathione peroxidase activity and deformability of erythrocytes in septic rats. J Pineal Res 35:138–139

    Article  PubMed  CAS  Google Scholar 

  79. Paskaloglu K, Sener G, Kapucu C, Ayanoglu-Dulger G (2004) Melatonin treatment protects against sepsis-induced functional and biochemical changes in rat ileum and urinary bladder. Life Sci 74:1093–1104

    Article  PubMed  CAS  Google Scholar 

  80. Acikel M, Buyukokuroglu ME, Aksoy H, Erdogan F, Erol MK (2003) Protective effects of melatonin against myocardial injury induced by isoproterenol in rats. J Pineal Res 35:75–79

    Article  PubMed  CAS  Google Scholar 

  81. Gitto E, Karbownik M, Reiter RJ, Tan DX, Cuzzocrea S, Chiurazzi P, Cordaro S, Corona G, Trimarchi G, Barberi I (2001) Effects of melatonin treatment in septic newborns. Pediatr Res 50:756–760

    Article  PubMed  CAS  Google Scholar 

  82. Hotchkiss RS, Karl IE (2003) The pathophysiology and treatment of sepsis. N Engl J Med 348:138–150

    Article  PubMed  CAS  Google Scholar 

  83. Jahnke G, Marr M, Myers C, Wilson R, Travlos G, Price C (1999) Maternal and developmental toxicity evaluation of melatonin administered orally to pregnant Sprague-Dawley rats. Toxicol Sci 50:271–279

    Article  PubMed  CAS  Google Scholar 

  84. Albuszies G, Bruckner UB (2003) Antioxidant therapy in sepsis. Intensive Care Med 29:1632–1636

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Intensive Care Unit, R Floor, Royal Hallamshire Hospital, Glossop Road, S10 2JF, Sheffield, UK

    Richard S. Bourne & Gary H. Mills

  2. Medical Economics and Research Centre, Sheffield (MERCS), R Floor, Royal Hallamshire Hospital, Glossop Road, S10 2JF, Sheffield, UK

    Gary H. Mills

Authors
  1. Richard S. Bourne
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gary H. Mills
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Richard S. Bourne.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bourne, R.S., Mills, G.H. Melatonin: possible implications for the postoperative and critically ill patient. Intensive Care Med 32, 371–379 (2006). https://doi.org/10.1007/s00134-005-0061-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00134-005-0061-x

Keywords

Search

Navigation